Navigation Links
Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42
Date:8/12/2008

accounts payable 14.1 18.3

Accrued compensation 24.4 20.6

Accrued customer rebates 18.3 20.3

Other current liabilities 19.4 16.6

Due to Hill-Rom Holdings, Inc. 9.1 -

Total current liabilities 195.3 75.8

Deferred compensation, long-term portion 7.3 8.6

Accrued pension and postretirement

healthcare, long-term portion 37.8 28.1

Other long-term liabilities 41.0 23.2

Total Liabilities 281.4 135.7

Commitments and Contingencies

SHAREHOLDERS' EQUITY

Parent company equity - 193.5

Common stock, no par value - -

Additional paid-in-capital 284.3 -

Retained earnings 15.2 -

Accumulated other comprehensive loss (14.5) (12.6)

Total Shareholders' Equity 285.0 180.9

Total Liabilities and Shareholders' Equity $566.4 $316.6

Hillenbrand, Inc.

Consolidated Statements of Cash Flows (Unaudited)

(Dollars in millions)

Nine Months Ended

June 30

2008 2007

Operating Activities:

Net income $74.0 $80.9

Adjustments to reconcile net income

to net cash flows from operating activities:

Depreciatio
'/>"/>

SOURCE Hillenbrand, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company
2. Hillenbrand, Inc. Names Joe A. Raver President and Chief Operating Officer of Batesville Casket Company
3. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...LOSANGELES,Nov.25/PRNewswire-USNewswire/--TheBlack...odetermineexecutiveleadershipfor2010. ,, Thenew...cialtiesinpublicpolicy,law,finance,governmenthealt...eBoardalsocomesfromawiderangeofpersonalbackgrounds...melivingwithHIVthemselves,andrepresentingmultiplea...
(Date:11/25/2009)...erm survivors of testicular cancer who were treate...e side effects, including neurological side effect...t treated with chemotherapy, according to a new st...f the National Cancer Institute . , Marianne Bry... University Hospital, in Bergen, Norway, and colle...
(Date:11/25/2009)...tress increase blood pressure? This simple questi... years. New Stress-related gene Modulates High Bl...blood pressure? This simple question has been the...w research has for the first time established a li...pressure response to stress in mice as well as hum...
(Date:11/25/2009)... Evaluation and treatment clinics... Woodstock (Vocus) November 25, 2009 -- Centegr...vaccines and H1N1 vaccine shots at four Centegra P...r shipment of vaccine has arrived. The clinics are...and McHenry and will be open as follows: , &nb...
(Date:11/25/2009)...positive note, CDC sees few signs of trouble with ...5 (HealthDay News) -- The ongoing H1N1 swine flu p... pneumonias among younger patients, a U.S. health ...crease in serious pneumococcal infections around t...tional Center for Immunization and Respiratory Dis...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...mericans diagnosed with primary open angle glaucom...or the condition according to a study. Th...rapy use in the U.S. to utilize longitudinal data ...ed 65 and older by analyzing data collected from 1...
...nistration (FDA) today issued a formal written req...l devices remaining in the marketplace, including...ns. On April 17, 2007, U.S. Marshals, at F...'s manufacturing processes. During the seizure, Sh...
...ght not only face the risk of developing health di...they are also likely to face the risk of developi...r 17 years, the study - by researchers at the Canc...for men and 85 for women significantly increases c...
...nistration (FDA) is warning pharmaceutical manufac...essionals who compound medications to be especial... commonly used worldwide in liquid over-the-counte...the agency is issuing guidance to industry recomme...
... as the most brisk walkers in the world, as the sp...en percent in the last decade. In a sampl... on top followed by citizens of Copenhagen, Madrid...the study. But walking fast is not good f...
...Bobby Robson is ready to fight against cancer for ...ho said that he was diagnosed with cancer for the ...y last week after cancerous nodules were discovere...e greatest news I've ever had but I have fought ha...
Other Medicine News:Health News:FDA Advises Manufacturers to Test Glycerin for Possible Contamination 2Health News:Bobby Robson Diagnosed With Cancer for Fifth Time 2
(Date:11/25/2009)...stCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevi...sruptivesurgicaltreatmentsforthespine,announcedtod...,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwil...Company,sproductsandwillincludecommentsfrommanagem...l-innumbersare1-877-407-4018fordomesticcallersand1...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...elivery-USMarketTrends&Analysis http://www.re...-US-Market-Trends--Analysis.html ,, TheUSintra...erapeuticapplicationsfromthedeliveryofconventional...euticdrugs.Thefutureofthetechnologyhingesontotheef...
(Date:11/25/2009)...ewswire/-- ChemoCentryx,Inc.,announcedtodaythatPh...ProspectiveRandomizedOralTherapyEvaluationinCrohn,...swithmoderate-to-severeCrohn,sdiseasedemonstratedc...profile.Thestudydemonstratedevidenceofclinicaleffi...pointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Study finds colorectal cancer rates increasing worldwide 8769 1Study finds colorectal cancer rates increasing worldwide 8769 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 1Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2
... for Presentation at 47th ICAAC on ..., Sept. 4 Ardea Biosciences,Inc. (Pink Sheets: AR...eted,Phase 1 single-ascending-dose, multiple-ascen...es of RDEA806, a novel HIV non-nucleoside reverse,...eers. The data from these Phase 1 clinical trials...
...ive analysis of,clinical trials known as a meta-an...tent was associated with significantly lower risks...mpared to the Taxus Stent out to 30,months after a...randomized,clinical trials and 8,695 patients, the...ed on the Journal of the American College of Cardi...
Other Medicine Technology:Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
Neuropack MEB-7102 Evoked Potential Measuring System
Neuropack MEB-2200 Evoked Potential/EMG Measuring System
Myoquick 1200/1400/1800
Sierra Wave
Medicine Products: